Indivior (LON:INDV) Shares Down 15.7% - Here's Why

Indivior PLC (LON:INDV - Get Free Report) traded down 15.7% during trading on Thursday . The stock traded as low as GBX 548.71 ($6.90) and last traded at GBX 732 ($9.21). 1,888,371 shares were traded during trading, an increase of 166% from the average session volume of 709,477 shares. The stock had previously closed at GBX 868 ($10.92).

Analyst Upgrades and Downgrades

Separately, Jefferies Financial Group restated a "buy" rating and issued a GBX 1,800 ($22.65) price target on shares of Indivior in a research note on Tuesday, December 17th.

Indivior Trading Down 15.7 %

The company has a market capitalization of £1.14 billion, a price-to-earnings ratio of -606.93, a P/E/G ratio of -5.57 and a beta of 0.19. The company has a debt-to-equity ratio of -170.06, a current ratio of 0.83 and a quick ratio of 1.52. The business's 50-day moving average price is GBX 928.06 and its two-hundred day moving average price is GBX 853.71.

About Indivior

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.